EVEROLD LONG TERM FOLLOW-UP
ConditionTransplant; Complication, Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest
About this trial
Long Term Follow up of EVEROLD study
Eligibility criteria
Qualifiers
Informed patients participating to the EVEROLD study
Patient having completed the EVEROLD M12 follow-up visit
Patient agreeing to participate in the observational study
Disqualifiers
Opposition to the use his medical data
Patient under legal protection
Trial design
Treatments tested in this trial
- Not listed
Trial groups
260 Participants
are grouped into 3 trial groupsLocations
14Chu Amiens Amiens France
CHU Bordeaux Bordeaux France
Chu Brest Brest France
CHU Lille Lille France
Sponsors and collaborators
University Hospital, Brest
Lead sponsor
Source ClinicalTrials.gov